Management of Boils (Furuncles)
Primary Treatment: Incision and Drainage
Incision and drainage (I&D) alone is the definitive treatment for uncomplicated boils, achieving cure rates of 85-90% without antibiotics. 1
Small Boils
- Apply warm, moist compresses several times daily to promote spontaneous drainage 1, 2
- This conservative approach is sufficient for uncomplicated small lesions in otherwise healthy patients 2
Large Boils
- Perform incision and drainage by making an incision over the fluctuant area, thoroughly evacuating pus, and probing the cavity to break up loculations 3
- After drainage, cover the surgical site with a dry dressing rather than packing with gauze—packing adds unnecessary pain without improving outcomes 1, 2
- Wound packing may be considered only for wounds larger than 5 cm to reduce recurrence 4
- Gram stain and culture are rarely necessary for simple large furuncles after adequate I&D 2
When to Add Systemic Antibiotics
Antibiotics should be added ONLY when high-risk features are present, not routinely after adequate drainage. 1
Specific Indications for Antibiotics:
- Systemic signs: fever (>38°C or <36°C), tachypnea (>24 breaths/min), tachycardia (>90 bpm), or abnormal WBC count (>12,000 or <4,000 cells/µL) 1
- Extensive surrounding cellulitis 1, 2
- Multiple lesions occurring simultaneously 1, 2
- Difficult-to-drain locations (face, hand, genital area) 1
- Immunocompromising conditions or markedly impaired host defenses 1, 2
- Lack of clinical response to I&D alone 1
- Associated septic phlebitis 1
Antibiotic Selection (When Indicated)
First-Line Oral Agents (in order of preference):
- Clindamycin 300-450 mg PO three times daily—first choice for MRSA coverage 1
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1, 2
- Doxycycline or minocycline 1, 2
- These agents provide coverage against Staphylococcus aureus including MRSA, reflecting high community prevalence 1, 2
- For confirmed methicillin-susceptible S. aureus (MSSA), use dicloxacillin or first-generation cephalosporins (e.g., cephalexin) 1, 3
Treatment Duration:
- 5-10 days of oral therapy, individualized according to clinical response 1
Safety Considerations:
- TMP-SMX: Use caution in elderly patients on renin-angiotensin system inhibitors or with chronic renal insufficiency due to hyperkalemia risk; avoid in third-trimester pregnancy and infants younger than 2 months 1
- Rifampin should NOT be used as single agent or adjunctive therapy for skin infections 1
Management of Recurrent Furunculosis
Risk Assessment:
- Nasal colonization with S. aureus occurs in 20-40% of the general population and is the primary risk factor for recurrence 2
- Inadequate personal hygiene and exposure to individuals with furuncles are additional predisposing factors 2
- Obesity, diabetes, smoking, young age (<30 years), and recent antibiotic use increase recurrence risk 5
Decolonization Strategy:
- Intranasal mupirocin 2% ointment applied twice daily to anterior nares for the first 5 days each month—reduces recurrences by approximately 50% 1, 2
- Daily chlorhexidine body washes 1, 2
- Oral clindamycin 150 mg daily for 3 months decreases subsequent infections by roughly 80% in susceptible S. aureus cases 2
- Daily decontamination of personal items including towels, sheets, and clothing 1, 2
Additional Preventive Measures:
- Culture recurrent abscesses early to identify causative organism and guide antibiotic selection 1
- Evaluate household members for S. aureus colonization and treat carriers if ongoing transmission is suspected 1
- Use separate towels and washcloths for each individual 2
Common Pitfalls to Avoid
- Do not routinely prescribe antibiotics for simple boils after adequate drainage—this contributes to antimicrobial resistance without improving outcomes 1, 3
- Do not perform needle aspiration of abscesses—it has low success rates and is not recommended 3
- Do not confuse furuncles with hidradenitis suppurativa, which requires different management 3
- Do not overlook facial furuncles—untreated facial infections can lead to life-threatening complications 6
- Warn patients to return immediately if signs of systemic infection develop (malaise, tachycardia, fever) 2